SMAD2 and nasopharyngeal carcinoma: Decrease in MACC1 level can inhibit NPC cell proliferation and stemness via the Akt/β-catenin pathway (11) and Smad2/MACC-1-AS1 (antisense long non-coding RNA (lncRNA) MACC-1-AS) axis (36), respectively.